← ANALYSTS · TIPRANKS
Edward Nash · Canaccord Genuity
Hits
52%
225 of 433 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+29.5%
Over a year after the rating, TipRanks’ measure
Our companies rated now
14
Buy / hold / sell: 14 / 0 / 0
Upside of the analyst’s targets
+264.6%
Average over 14 current targets, to the last price
The market’s answer to the ratings
−4.2%
Day-0 move against SPY in the rating’s direction, average over 5 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 14on TipRanks Oct 15 07:30 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $114 | +352.9% | −3.3%next day +7.2% | ↗ |
| Oct 14on TipRanks Oct 15 07:30 | CORTCorcept Therapeutics · $12.9B | Reiterated | Buy | $161 | +46.2% | −0.3%next day −2.7% | ↗ |
| Oct 13on TipRanks 07:10 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $50.00 → $60.00+20.0% | +74.1% | −6.9%next day +8.8% | ↗ |
| Oct 9on TipRanks 07:11 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $50.00 | +45.1% | −1.1%next day +7.0% · 5 days +10.2% | ↗ |
| Oct 7on TipRanks 07:11 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $114 | +352.9% | +0.8%next day −2.4% · 5 days −9.8% | ↗ |
| Oct 1on TipRanks 07:10 | CNTBIWMConnect Biopharma Holdings · $57M | Reiterated | Buy | $6.00 | +562.3% | −11.2%next day −6.1% · 5 days −11.4% | ↗ |
| Oct 1on TipRanks 07:10 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $56.00 | +598.3% | −5.3%next day −3.2% · 5 days −6.1% | ↗ |
| Sep 30on TipRanks 05:25 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Initiated | Buy | $50.00 | +45.1% | −1.3%next day −4.5% · 5 days −15.6% | ↗ |
| Sep 29on TipRanks 07:20 | IVAInventiva · $877M | Reiterated | Buy | $20.00 → $21.00+5.0% | +614.3% | −6.6%next day +12.4% · 5 days +3.2% | ↗ |
| Sep 28on TipRanks 06:55 | NKTRIWMNektar Therapeutics · $1.3B | Reiterated | Buy | $153 | +327.6% | +6.6%next day −1.7% · 5 days −31.3% | ↗ |
| Sep 23on TipRanks 07:15 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $114 | +352.9% | +2.7%next day −11.7% · 5 days −21.1% | ↗ |
| Sep 23on TipRanks 07:15 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $60.00 | +117.9% | −6.4%next day +1.2% · 5 days +4.8% | ↗ |
| Sep 16on TipRanks 06:55 | CNTBIWMConnect Biopharma Holdings · $57M | Reiterated | Buy | $7.00 → $6.00−14.3% | +562.3% | +6.4%next day +2.9% · 5 days −15.8% | ↗ |
| Sep 1on TipRanks 06:30 | ACRSIWMAclaris Therapeutics · $514M | Initiated | Buy | $10.00 | +204.9% | +0.2%next day +2.2% · 5 days −7.7% | ↗ |
| Aug 17on TipRanks Aug 13 08:40 | RANIRani Therapeutics Holdings · $113M | Reiterated | Buy | $5.00 | +681.2% | −1.3%next day +0.1% · 5 days +8.7% | ↗ |
| Aug 13on TipRanks 07:15 | CORTCorcept Therapeutics · $12.9B | Reiterated | Buy | $161 | +46.2% | −2.2%next day +3.8% · 5 days +11.5% | ↗ |
| Aug 12on TipRanks Aug 13 08:40 | KNSAIWMKiniksa Pharmaceuticals · $6.2B | Reiterated | Buy | $98.00 | +24.7% | +0.2%next day −1.1% · 5 days +3.8% | ↗ |
| Aug 11on TipRanks Aug 12 07:35 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $56.00 | +598.3% | −0.2%next day −1.6% · 5 days +11.5% | ↗ |
| Aug 11on TipRanks Aug 12 07:35 | TVTXIWMTravere Therapeutics · $5.0B | Reiterated | Buy | $70.00 | +41.1% | −0.8%next day +3.0% · 5 days +6.5% | ↗ |
| Aug 11on TipRanks Aug 12 07:20 | MDGLMadrigal Pharmaceuticals · $10.4B | Reiterated | Buy | $612 | +36.1% | +4.2%next day −0.1% · 5 days −1.6% | ↗ |
| Aug 6on TipRanks 07:06 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $129 | +23.1% | +1.0%next day +0.4% · 5 days +6.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗